the potential of targeted therapy in dlbcl: open questions
Published 7 years ago • 89 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
0:42
targeted therapies for dlbcl treatment
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
3:05
car-t therapy in r/r dlbcl
-
3:21
safety management of car-t cell therapy in dlbcl
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:54
novel treatment strategies in t-cell lymphomas
-
5:54
day in the life - haematology - dr ellen maxwell
-
12:12
immune checkpoint proteins
-
1:00:09
webinar: new checkpoint molecules that regulate anti-tumor immunity
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
10:51
update of targeted or chemotherapy-free therapies in lymphoma
-
7:16
changes in the classification of dlbcl
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
2:42
the role of ibrutinib in dlbcl and the value of next-generation btk inhibitors
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
3:04
applying molecular understanding of dlbcl to management strategies
-
4:08
utilizing biology to improve on r-chop in dlbcl: targeting ubiquitous markers & mutational analysis
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
1:16
predictors of long-term survival in patients with dlbcl/hgbcl following autosct